BODIPY 581/591 C11 (Lipid Peroxidation Sensor) #95978
- IF
- F
Product Information
Product Usage Information
1. BODIPY 581/591 C11 (Lipid Peroxidation Sensor): Create a 10 mM stock solution by dissolving 1 mg of BODIPY 581/591 C11 (Lipid Peroxidation Sensor) into 198.26 μL of high-quality anhydrous DMSO.
Additional Reagents (Not Supplied):
1. Hanks' Balanced Salt Solution (HBSS)
2. DMSO (Dimethyl Sulfoxide), Sterile #12611
Protocol:
1. Incubate cells with 1 - 2 µM of BODIPY 581/591 C11 (Lipid Peroxidation Sensor) and 1 μM of Hoechst 33342 #4082 (optional) in cell culture media for 30 min.
2. Wash two times with HBSS.
3. Add desired treatments in HBSS and incubate as needed.
4. Examine cells by fluorescence microscopy. Refer to the Fluorescent Properties section for excitation and emission spectra.
5. For analysis by flow cytometry, dissociate adherent cells or collect suspension cells. Viability dye can be used if desired. Analyze on a flow cytometer at desired cell density.
Storage
Fluorescent Properties
Excitation/Emission Max: 581/591 nm
After Oxidation Excitation/Emission Max: 488/510 nm
Product Description
BODIPY 581/591 C11 (Lipid Peroxidation Sensor) is a fluorescent dye that localizes to membranes and is used to measure lipid peroxidation in live cells. It is a highly sensitive fluorescent probe that has a shift in fluorescent emission upon oxidation of the polyunsaturated butadienyl portion of its fatty acid analog in live cells. When this occurs, fluorescence emission peaks shift from red (~590 nm) to green (~510 nm). BODIPY 581/591 C11 (Lipid Peroxidation Sensor) measures lipid peroxidation through the ratiometric shift in fluorescence between reduced and oxidized states of the probe.
Lipid peroxidation is the free radical oxidative degradation of lipids from excessive reactive oxygen species production. Oxidative damage to lipids produces lipid peroxides that can cause damage to cell membranes, leading to changes downstream in signaling pathways, eventually leading to cell death. Lipid peroxidation can occur during apoptotic cell death but has been recognized as a defining characteristic of the non-apoptotic cell death pathway ferroptosis. Ferroptosis is defined by iron-dependent, lipid peroxidation. An increase in ferroptosis occurs during aging, and pathologies including cancer, atherosclerosis, neurodegeneration, and cardiovascular disease.
| Molecular Weight | 504.4 g/mol |
| CAS | 217075-36-0 |
Limited Uses
Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.
Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.